Multicenter Analysis Of Gestational Trophoblastic Neoplasia In Turkey
Göster/ Aç
Tarih
2014Yazar
Ozalp, Sabit Sinan
Telli, Elcin
Oge, Tufan
Tulunay, Gokhan
Boran, Nurettin
Turan, Taner
Yenen, Mufit
Kurdoglu, Zehra
Ozler, Ali
Yuce, Kunter
Ulker, Volkan
Arvas, Macit
Demirkiran, Fuat
Bese, Tugan
Tokgozoglu, Nedim
Onan, Anil
Sanci, Muzaffer
Gokcu, Mehmet
Tosun, Gokhan
Dikmen, Yilmaz
Ozsaran, Aydin
Terek, Mustafa Cosan
Akman, Levent
Yetimalar, Hakan
Kilic, Derya Sakarya
Gungor, Tayfun
Ozgu, Emre
Yildiz, Yunus
Kokcu, Arif
Kefeli, Mehmet
Kuruoglu, Serkan
Yuksel, Hasan
Guvenal, Tevfik
Hasdemir, Pinar Solmaz
Ozcelik, Bulent
Serin, Serdar
Dolanbay, Mehmet
Arioz, Dagistan Tolga
Tuncer, Nadire
Bozkaya, Hasan
Guven, Suleyman
Kulaksiz, Deniz
Varol, Fusun
Yanik, Ali
Ogurlu, Gonca
Simsek, Tayyup
Toptas, Tayfun
Dogan, Selen
Camuzoglu, Hakan
Api, Murat
Guzin, Kadir
Caliskan, Eray
Doger, Emek
Cakmak, Bulent
Ilhan, Tolgay Tuyan
Üst veri
Tüm öğe kaydını gösterÖzet
Background: To evaluate the incidence, diagnosis and management of GTN among 28 centers in Turkey. Materials and Methods: A retrospective study was designed to include GTN patients attending 28 centers in the 10-year period between January 2003 and May 2013. Demographical characteristics of the patients, histopathological diagnosis, the International Federation of Gynecology and Obstetrics (FIGO) anatomical and prognostic scores, use of single-agent and multi-agent chemotherapy, surgical interventions and prognosis were evaluated. Results: From 2003-2013, there were 1,173,235 deliveries and 456 GTN cases at the 28 centers. The incidence was calculated to be 0.38 per 1,000 deliveries. According to the evaluated data of 364 patients, the median age at diagnosis was 31 years (range, 15-59 years). A histopathological diagnosis was present for 45.1% of the patients, and invasive mole, choriocarcinoma and PSTTs were diagnosed in 22.3% (n=81), 18.1% (n=66) and 4.7% (n=17) of the patients, respectively. Regarding final prognosis, 352 (96.7%) of the patients had remission, and 7 (1.9%) had persistence, whereas the disease was mortal for 5 (1.4%) of the patients. Conclusions: Because of the differences between countries, it is important to provide national registration systems and special clinics for the accurate diagnosis and treatment of GTN.